COCHW

Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully…

Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company…

White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will…

Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final Clinical PMA Module by End of Q2 2027White Bear Lake,…

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc.

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc.

Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of +22.22% and -15.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Submitted First Module of Modular PMA Application to FDASubsequent to Quarter End, the Company Reported Positive 12-Month Stage 1 Data Showing Continued Improvement in Speech Perception White Bear Lake, Minnesota--(Newsfile Corp.

Envoy Medical, Inc. (COCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) - Envoy Medical® Inc.

Envoy Medical Inc. (NASDAQ:COCH) on Tuesday said it surpassed the three-month milestone for all 56 patients enrolled in the company’s pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant.

Mean CNC word recognition scores for Stage 1 cohort improved to 53.2% at 12 months from 15.2% pre-implantation, a 38.0 percentage point gain that continued to build on the 24.0 percentage point improvement reported at 6 monthsWhite Bear Lake, Minnesota--(Newsfile Corp.